10x Genomics, Inc. (FRA:1KJ)

Market Cap	2.15B +22.1%
Revenue (ttm)	547.02M +1.9%
Net Income	-65.05M
EPS	-0.53
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	88
Open	17.12
Previous Close	17.41
Day's Range	17.12 - 17.12
52-Week Range	6.12 - 19.96
Beta	n/a
RSI	51.49
Earnings Date	Feb 12, 2026

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as ...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2012
• Employees: 1,306
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1KJ

Financial Performance

In 2024, 10x Genomics's revenue was $610.79 million, a decrease of -1.28% compared to the previous year's $618.73 million. Losses were -$182.63 million, -28.41% less than in 2023.

Financial numbers in USD